Studies of glioblastomas and EGFR have focused on the effects EGFRvIII has in up-regulating the PI3K/Akt pathway as the mechanism behind the tumorigenicity of EGFRvIII [22,23]. The gene discussed is AKT1; the disease is glioblastoma.